DFTX
Definium Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$38.09
+0.24%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 57.71x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.57x
- Price / sales
- —
- Price / cash flow
- -30.67x
Enterprise value
- Enterprise value
- $4.1B
- EV / sales
- —
- EV / EBITDA
- -11.98x
- EV / EBIT
- -17.89x
- Market cap
- $5.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026